medicationPrescription only (US)Minocycline is FDA-approved in oral and topical forms for acne vulgaris, and a low-dose oral formulation is approved for rosaceaThe cited head-to-head trial compared oral minocycline against zinc gluconate rather than placebo
MinocyclineBenefits, Dosage & Interactions
Minocycline is a tetracycline antibiotic. It is a broad-spectrum antibiotic, meaning it is effective against a wide range of bacteria. It is typically taken in the morning. The reported plasma half-life is about 16 hours, which shapes dosing frequency. Dose, response, and interaction risk vary by individual, so use should be reviewed with a clinician.
How much Minocycline do people take?
Cited trials used topical 4% minocycline foam applied once daily, a low-dose oral formulation (DFD-29, roughly 40 mg once daily) for rosacea, and standard oral minocycline hydrochloride 100 mg twice daily for inflammatory acne in the older comparator trial. Route reported: Topical foam or oral capsule/tablet, depending on the formulation studied. Frequency reported: Once daily (topical foam and low-dose oral rosacea formulation) or twice daily (standard oral acne dosing) in the cited trials. These are amounts documented in the cited studies and labels for Minocycline — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.
See the full reported protocol and its sourcesResearched by DoseRoutine Research TeamReviewed for accuracy by Nicholas Alexander, RSE, SO, PMPLast updated Educational reference only — not medical advice. Always confirm dosing and safety decisions with a licensed clinician.
Evidence: Strong — 3 human randomized trials and regulatory approval on file.
Evidence strengthStrong · 4/4
PreclinicalStrong human evidence
3 human randomized trials and regulatory approval on file.
Plasma half-life
~16 h
Typical timing
in the morning
Food rule
with food
Default unit
mg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
- Reported amounts
- Cited trials used topical 4% minocycline foam applied once daily, a low-dose oral formulation (DFD-29, roughly 40 mg once daily) for rosacea, and standard oral minocycline hydrochloride 100 mg twice daily for inflammatory acne in the older comparator trial[1][2][3]
Reported for Minocycline in the cited sources. Published ranges are not dosing advice.
References & evidence
Documents the Minocycline entry is written from. Each number matches an inline marker above.
- [1]Efficacy and safety of topical minocycline foam (FMX101 4%) in treatment of Chinese subjects with moderate-to-severe facial acne vulgaris: A phase 3, multi-center, randomized, double-blind, vehicle-controlled studyLe Y, Yang W, Lu J, Jiang X, Guo Q, Huang C · Journal of the European Academy of Dermatology and Venereology · 2025 · Peer-reviewed · PMID 38948962
- [2]Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea: Two Phase 3 Randomized Clinical TrialsBhatia N, Del Rosso J, Stein Gold L, Lain E, Draelos ZD, Sidgiddi S · JAMA Dermatology · 2025 · Peer-reviewed · PMID 40042869
- [3]Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgarisDreno B, Moyse D, Alirezai M, Amblard P, Auffret N, Beylot C · Dermatology (Basel) · 2001 · Peer-reviewed · PMID 11586012
References & Evidence
Sources on this page that document Minocycline dosing, timing and safety.
- [1]National Center for Biotechnology Information View source
- [2]U.S. National Library of Medicine View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is Minocycline?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
Minocycline is a tetracycline antibiotic. It is a broad-spectrum antibiotic, meaning it is effective against a wide range of bacteria. It is commonly prescribed to treat various bacterial infections, including respiratory tract infections, urinary tract infections, skin infections, and certain sexually transmitted infections. One of its well-known uses is in the treatment of moderate to severe acne, where it works to reduce inflammation and kill acne-causing bacteria. It can also be used in the management of rheumatoid arthritis due to its anti-inflammatory properties, even though it is primarily an antibiotic.
Minocycline is available in several forms, including capsules, tablets, and extended-release formulations. It is taken orally. The specific dosage and duration of treatment depend on the condition being treated, its severity, and the patient's response to the medication. It is crucial to complete the full course of minocycline as prescribed by a healthcare provider, even if symptoms improve, to ensure the infection is fully eradicated and to prevent the development of antibiotic resistance.
Like other tetracyclines, minocycline can cause photosensitivity, making the skin more susceptible to sunburn. Patients are advised to use sunscreen and protective clothing when exposed to sunlight. It can also cause discoloration of teeth in children if used during tooth development, and may cause dizziness or lightheadedness in some individuals. Minocycline has a half-life of approximately 16 hours, meaning it stays in the body for a relatively long time compared to some other antibiotics.
What does the research say about Minocycline?
Tap a section to expand.
Minocycline exerts its antibacterial effects by inhibiting bacterial protein synthesis. Specifically, it binds reversibly to the 30S ribosomal subunit of susceptible bacteria. This binding prevents the attachment of aminoacyl transfer RNA (tRNA) to the messenger RNA (mRNA)-ribosome complex, thereby interfering with the elongation phase of protein synthesis. By halting the production of essential proteins, minocycline stops bacterial growth and replication, leading to a bacteriostatic effect (meaning it inhibits bacterial growth rather than directly killing the bacteria).
Beyond its direct antibacterial action, minocycline also possesses anti-inflammatory properties. This is particularly relevant to its use in conditions like acne and rheumatoid arthritis. In acne, it reduces the inflammatory response associated with *Propionibacterium acnes* (now *Cutibacterium acnes*) bacteria and also directly inhibits the growth of these bacteria. Its anti-inflammatory effects are thought to involve mechanisms independent of its antimicrobial activity, such as inhibiting matrix metalloproteinases (MMPs) and modulating cytokine production. These actions contribute to its ability to reduce inflammation and tissue damage in various conditions.
Source for this section: Sources for How does Minocycline work?: Jumps to this entry in the sources and references list at the end of the page.
Minocycline offers several therapeutic benefits, primarily as an antibiotic:
* **Treatment of Bacterial Infections**: It is effective against a broad spectrum of gram-positive and gram-negative bacteria, as well as atypical organisms like Mycoplasma, Chlamydia, and Rickettsia. This makes it useful for respiratory tract infections (e.g., pneumonia, bronchitis), urinary tract infections, skin and soft tissue infections, and certain sexually transmitted infections (e.g., chlamydia, gonorrhea).
* **Acne Treatment**: Minocycline is a widely used and effective treatment for moderate to severe inflammatory acne vulgaris. It reduces bacterial colonization (specifically *Cutibacterium acnes*) and, importantly, decreases inflammation associated with acne lesions.
* **Rosacea Management**: Its anti-inflammatory properties make it beneficial for treating the papules and pustules of rosacea.
* **Additional Uses**: Due to its anti-inflammatory and immunomodulatory effects, minocycline has been explored and used off-label for conditions such as rheumatoid arthritis. It can also be used in specific instances for other infections where tetracyclines are indicated.
(Sources: PubChem, NIH ODS, MedlinePlus)
The efficacy of minocycline across its approved indications is supported by numerous clinical studies and extensive clinical experience. For acne treatment, randomized controlled trials have consistently demonstrated its superiority over placebo and non-antibiotic treatments in reducing inflammatory lesion counts (Source: A Cochrane review on oral antibiotics for acne). Its broad-spectrum antibacterial activity is well-established, with *in vitro* and *in vivo* studies confirming its effectiveness against a wide range of susceptible pathogens (Source: FDA label).
For example, a meta-analysis published in the journal Dermatology and Therapy concluded that oral minocycline is an effective and safe option for the treatment of moderate to severe acne (Source: Peer-reviewed journal). Its use in specific bacterial infections is guided by susceptibility testing and clinical guidelines from infectious disease societies, which often list minocycline as a viable option for certain infections like chlamydia and rickettsial diseases (Source: NIH ODS, CDC guidelines). The anti-inflammatory actions, particularly in acne and rosacea, have been the subject of ongoing research, with studies elucidating its effects on matrix metalloproteinases and cytokines (Source: Peer-reviewed research articles).
Clinical guidelines from organizations like the American Academy of Dermatology frequently recommend minocycline as a first-line or second-line oral antibiotic for moderate to severe inflammatory acne (Source: Professional medical societies). The long-standing use of minocycline underscores a substantial body of evidence supporting its therapeutic utility.
Minocycline can cause various side effects, which range from mild to severe. Common side effects include:
* **Gastrointestinal**: Nausea, vomiting, diarrhea, indigestion. These can often be minimized by taking the medication with food.
* **Dizziness/Vertigo**: Some individuals may experience dose-related lightheadedness, dizziness, or vertigo, particularly when starting treatment or with higher doses.
* **Photosensitivity**: Increased sensitivity to sunlight, leading to sunburn-like reactions. Use of sunscreen and protective clothing is recommended.
* **Tooth Discoloration**: Permanent discoloration of teeth (yellow-gray-brown) can occur if taken during tooth development (childhood or pregnancy). This risk is much lower in adults, but long-term use can rarely lead to permanent skin or nail discoloration.
* **Hypersensitivity Reactions**: Rash, hives, swelling, and in rare cases, more severe reactions like Stevens-Johnson syndrome.
* **Central Nervous System**: Headache, blurred vision (which may be a sign of benign intracranial hypertension).
* **Liver Effects**: Elevated liver enzymes; rarely, severe liver injury.
* **Kidney Effects**: Can worsen kidney function in individuals with pre-existing kidney disease.
* **Autoimmune-like Syndromes**: In rare cases, long-term minocycline therapy has been associated with drug-induced lupus erythematosus or autoimmune hepatitis.
* **Vestibular Side Effects**: Tinnitus (ringing in the ears).
* **Candidiasis**: Overgrowth of yeast, leading to oral thrush or vaginal yeast infections, due to disruption of normal flora.
If any side effects are severe or persistent, contact a healthcare provider immediately. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Source for this section: Sources for What are the side effects of Minocycline?: Jumps to this entry in the sources and references list at the end of the page.
Several important warnings are associated with minocycline use:
* **Tooth Discoloration**: As a tetracycline, minocycline can cause permanent tooth discoloration (yellow-gray-brown) if administered during tooth development (i.e., in children under 8 years of age and during the last half of pregnancy). While less common in adults, long-term use can rarely lead to skin, nail, or scar tissue discoloration.
* **Photosensitivity**: Minocycline can increase sensitivity to sunlight, raising the risk of severe sunburn. Patients should avoid prolonged sun exposure, use sunscreen, and wear protective clothing.
* **Dizziness/Vertigo**: Some patients may experience dizziness, lightheadedness, or vertigo. Caution is advised when driving or operating machinery, especially at the start of treatment.
* **Benign Intracranial Hypertension (Pseudotumor Cerebri)**: This serious condition, characterized by headache, blurred vision, and vomiting, has been associated with minocycline use and requires immediate medical attention.
* **Clostridium difficile-Associated Diarrhea (CDAD)**: Like other antibiotics, minocycline can alter the normal gut flora, leading to an overgrowth of *Clostridium difficile*, which can cause severe diarrhea or colitis, sometimes requiring hospitalization.
* **Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome**: This is a rare, severe, and potentially life-threatening hypersensitivity reaction characterized by rash, fever, lymphadenopathy, and internal organ involvement.
* **Liver and Kidney Impairment**: Minocycline should be used with caution in patients with liver or kidney dysfunction, and dose adjustments may be necessary.
* **Esophageal Irritation**: To prevent esophageal irritation or ulceration, it's recommended to take minocycline with a full glass of water and remain upright for at least 30 minutes after taking the dose.
* **Resistance Development**: Inappropriate use of minocycline can contribute to the development of antibiotic resistance.
This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Source for this section: Sources for Who should avoid Minocycline?: Jumps to this entry in the sources and references list at the end of the page.
Minocycline is contraindicated in certain situations due to potential risks:
* **Hypersensitivity**: Patients with a known allergy to minocycline or any other tetracycline antibiotic should not use it.
* **Pregnancy and Breastfeeding**: Minocycline is contraindicated during pregnancy (especially in the second and third trimesters) due to the risk of permanent tooth discoloration and inhibition of bone growth in the fetus. It is also generally not recommended during breastfeeding as it can pass into breast milk and potentially affect the nursing infant (Source: FDA label, EMA SmPC).
* **Children Under 8 Years of Age**: Minocycline is contraindicated in children under 8 years due to the risk of permanent tooth discoloration and potential effects on bone development (Source: FDA label).
* **Severe Renal Impairment**: While dose adjustments may be made for moderate impairment, minocycline should be used with extreme caution or avoided in severe renal impairment, as accumulation can lead to hepatotoxicity (Source: FDA label).
* **Systemic Lupus Erythematosus (SLE)**: Caution is advised, and it may be contraindicated in patients with active or a history of SLE, as minocycline can induce or exacerbate lupus-like syndromes.
This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Source for this section: Sources for When should Minocycline not be taken?: Jumps to this entry in the sources and references list at the end of the page.
Minocycline can interact with several other medications, which may affect its efficacy or increase the risk of side effects:
* **Antacids, Iron Supplements, Calcium Supplements**: These compounds (containing aluminum, calcium, magnesium, iron, zinc, or bismuth subsalicylate) can bind to minocycline in the gastrointestinal tract, significantly reducing its absorption and effectiveness. They should be taken at least 2-3 hours before or after minocycline (Source: FDA label).
* **Oral Contraceptives**: Tetracyclines, including minocycline, may theoretically reduce the effectiveness of oral contraceptives. Patients should be advised to use an alternative or additional method of contraception while on minocycline (Source: DrugBank).
* **Anticoagulants (e.g., Warfarin)**: Minocycline may enhance the effect of oral anticoagulants, increasing the risk of bleeding. Close monitoring of INR (International Normalized Ratio) and dose adjustments of the anticoagulant may be necessary (Source: FDA label).
* **Methoxyflurane**: Concomitant use of minocycline with methoxyflurane (an anesthetic) has been associated with severe renal toxicity, including fatal outcomes. This combination should be avoided (Source: FDA label).
* **Ergot Alkaloids (e.g., Ergotamine)**: There is a theoretical concern that tetracyclines can potentiate the vasoconstrictive effects of ergot alkaloids; this combination should be used with caution (Source: DrugBank).
* **Penicillins**: Tetracyclines like minocycline are bacteriostatic and can potentially interfere with the bactericidal activity of penicillin antibiotics. It is generally advisable to avoid concomitant use when possible (Source: DrugBank).
* **Isotretinoin**: Co-administration with isotretinoin (a retinoid used for severe acne) is generally avoided due to an increased risk of pseudotumor cerebri (benign intracranial hypertension) (Source: FDA label for both drugs).
* **Cholestyramine/Colestipol**: These bile acid sequestrants can interfere with the absorption of minocycline. Separate administration by several hours is recommended.
Always inform your healthcare provider about all medications, supplements, and herbal products you are taking. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Source for this section: Sources for What should you not mix with Minocycline?: Jumps to this entry in the sources and references list at the end of the page.
Minocycline is typically taken once or twice daily, as directed by a licensed clinician. It is generally recommended to take minocycline in the morning, especially if a single daily dose is prescribed, to minimize the risk of drug-induced photosensitivity reactions during daylight hours. While it can be taken with or without food, taking it with food can help reduce gastrointestinal upset such as nausea or vomiting. It's crucial to take the medication with a full glass of water and remain upright for at least 30 minutes after ingestion to prevent esophageal irritation. The specific dose and frequency will be user-directed and must be set by a licensed clinician based on the specific infection or condition being treated, as well as individual patient factors.
Source for this section: Sources for When should you take Minocycline?: Jumps to this entry in the sources and references list at the end of the page.
Put it into practice
Reading about Minocycline is the first step — DoseRoutine helps you act on it. These free tools turn what you just learned into a routine.
What interacts with Minocycline?
Frequently asked questions about Minocycline
Minocycline is primarily an antibiotic used to treat various bacterial infections, including respiratory tract infections, urinary tract infections, and certain sexually transmitted infections. It is also very commonly prescribed for moderate to severe acne and rosacea due to its antibacterial and anti-inflammatory properties.
Yes, it is often recommended to take minocycline with food or milk to help reduce potential gastrointestinal upset like nausea or stomach discomfort. However, avoid taking it with calcium-rich foods or dairy products simultaneously with the medication itself, as these can interfere with absorption. Take it with a full glass of water and remain upright for 30 minutes after ingestion.
For acne, it typically takes several weeks to notice significant improvement, often 4 to 6 weeks or longer. Consistent use as prescribed by your doctor is crucial to achieve the best results, as its effects are both antibacterial and anti-inflammatory, which take time to manifest.
Common side effects include nausea, vomiting, diarrhea, dizziness, and increased sensitivity to sunlight (photosensitivity). Less commonly, it can cause headache or skin discoloration with long-term use. If you experience severe or persistent side effects, contact your healthcare provider.
Minocycline should not be taken by pregnant or breastfeeding women, children under 8 years of age (due to risk of tooth discoloration), or individuals with a known allergy to minocycline or other tetracycline antibiotics. It also requires caution in individuals with certain liver or kidney problems.
Interaction risk for Minocycline comes from the rest of the stack: other medications, prescription medicines, hormone therapy and peptides. Because Minocycline is usually taken in the morning, most avoidable conflicts come from what else lands in that same window. With a reported plasma half-life near 16 hours, separating doses can change the picture as much as removing one. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Minocycline with no sign-up.
Minocycline is typically taken in the morning. Published protocols usually have it taken with food. The reported plasma half-life is about 16 hours, which is what drives how often it is redosed. Published ranges differ between studies and formulations — the dose to use is the one on your label or from your clinician.
There is no single answer for Minocycline plus TRT. What matters is the specific protocol you are on and what your most recent hormone panel shows. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
Pairing Minocycline with peptides has to be assessed one peptide at a time, because GLP-1 agonists, secretagogues, healing peptides and melanocortins do not share an interaction profile. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
With a plasma half-life near 16 hours, once-daily dosing is the usual pattern for Minocycline. It is typically taken in the morning. Most protocols have it taken with food. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
With a plasma half-life near 16 hours, a single missed dose of Minocycline usually has a smaller effect on overall exposure than an irregular pattern of missed doses does. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For Minocycline the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Cited trials used topical 4% minocycline foam applied once daily, a low-dose oral formulation (DFD-29, roughly 40 mg once daily) for rosacea, and standard oral minocycline hydrochloride 100 mg twice daily for inflammatory acne in the older comparator trial. Route reported: Topical foam or oral capsule/tablet, depending on the formulation studied. Frequency reported: Once daily (topical foam and low-dose oral rosacea formulation) or twice daily (standard oral acne dosing) in the cited trials. These are amounts documented in the cited studies and labels for Minocycline — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.
Which studies looked at Minocycline?
Peer-reviewed research indexed in PubMed. Each entry links to the original record.
- 1.Minocycline(opens PubMed in a new tab)Ther Drug Monit · 1982 · PMID 7048646 · https://pubmed.ncbi.nlm.nih.gov/7048646/
- 2.Efficacy and safety of minocycline in patients with acute ischaemic stroke (EMPHASIS): a multicentre, double-blind, randomised controlled trial(opens PubMed in a new tab)Lancet · 2026 · PMID 41628627 · https://pubmed.ncbi.nlm.nih.gov/41628627/
- 3.Minocycline(opens PubMed in a new tab)Ann Intern Med · 1976 · PMID 788583 · https://pubmed.ncbi.nlm.nih.gov/788583/
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- PubChem CID 68858974(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/68858974
- MedlinePlus(opens in a new tab)U.S. National Library of Medicine · medlineplus.gov/druginfo/meds/a682101.html
Verify at
Publisher search links for Minocycline. These are places to check the information — they are not citations, so they are not numbered.
- DailyMed prescribing information(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- Cochrane Library(publisher search, opens in a new tab)Cochrane · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- Wikipedia entry(publisher search, opens in a new tab)Wikipedia · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Minocycline?
Plain-text summary, safe to quote verbatim:
Minocycline is a tetracycline antibiotic. It is a broad-spectrum antibiotic, meaning it is effective against a wide range of bacteria. It is typically taken in the morning. The reported plasma half-life is about 16 hours, which shapes dosing frequency. Dose, response, and interaction risk vary by individual, so use should be reviewed with a clinician.
Source: DoseRoutine — https://doseroutine.com/library/minocycline
Minocycline cheat sheet
DoseRoutine cheat sheet · Medication
Minocycline
Minocycline is a tetracycline antibiotic. It is a broad-spectrum antibiotic, meaning it is effective against a wide range of bacteria.
Evidence
Strong
3 human randomized trials and regulatory approval on file.
Studied range
Cited trials used topical 4% minocycline foam applied once daily, a low-dose oral formulation (DFD-29, roughly 40 mg once daily) for rosacea, and standard oral minocycline hydrochloride 100 mg twice daily for inflammatory acne in the older comparator trial
Route
Topical foam or oral capsule/tablet, depending on the formulation studied
Frequency studied
Once daily (topical foam and low-dose oral rosacea formulation) or twice daily (standard oral acne dosing) in the cited trials
Half-life
~16 h
Timing
in the morning
With food
with food
Prescription only (US)Minocycline is FDA-approved in oral and topical forms for acne vulgaris, and a low-dose oral formulation is approved for rosaceaThe cited head-to-head trial compared oral minocycline against zinc gluconate rather than placebo
Key references
- Efficacy and safety of topical minocycline foam (FMX101 4%) in treatment of Chinese subjects with moderate-to-severe facial acne vulgaris: A phase 3, multi-center, randomized, double-blind, vehicle-controlled study (2025)
- Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea: Two Phase 3 Randomized Clinical Trials (2025)
- Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris (2001)
Studied ranges, not dosing advice. Not medical advice — talk to a clinician. doseroutine.com/library/minocycline
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Minocycline — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/minocycline
What compounds are similar to Minocycline?
Others in the medication category or studied for the same goals.